CS Paper Radar

SMARtCARE: Privacy-Preserving Agentic AI Systems for Bounded-Autonomy Clinical Decision Support

Srini Ramaswamy, Deveeshree Nayak

cs.AI cs.ETcs.SE ·submitted 2026-09-24 02:44 UTC · v1
published

Abstract

Long-context clinical AI systems can miss relevant patient history when prior admissions fall outside the active reasoning context. In ICU monitoring, this can cause early vital-sign drift to appear nonspecific even when it resembles a prior deterioration pattern. SMARtCARE addresses this gap through a four-state clinical decision-support architecture: Stable, Meta-cognitive, Assisted, and Regulated (Revoked). Rather than automatically retrieving prior records, SMARtCARE uses a lossy six-channel fingerprint of the patient's prior trajectory. When current drift matches that fingerprint and the prior record is absent from context, the system raises a Meta-cognitive escalation for clinician review; full retrieval occurs only through clinician action in the Assisted state. A patient-identity guard is designed to enforce correct attribution across data loading, logging, and audit layers. Evaluation combines a synthetic Monte Carlo study that validates the state-transition logic and estimator stability, not clinical performance, with real-data runs on both the MIMIC-III and MIMIC-IV Clinical Database Demos. On MIMIC-III, one prior-pattern recurrence was identified among 14 two-admission patients; on MIMIC-IV, the same pipeline produced no fingerprint matches among 9 two-admission patients, which illustrates a key limitation of a fixed canonical pattern library. Across both runs all logged decisions were fully traceable and correctly attributed. The results support SMARtCARE as a traceable, privacy-aware mechanism for surfacing middle-context risk; they are not a clinical efficacy claim.

Comment
Paper accepted to, and to appear in, the 2026 IEEE HealthCom Conference

Closest papers

Nearest neighbours by meaning across the whole index.

CareGraph: An Auditable Hybrid AI Framework for Evidence-Grounded Personalized Longitudinal Health Intelligence

cs.AI cs.IRcs.MA ·2026-08-25 ·Pratik Ghawate, Tanvi Patil
benchmarkcode/data similarity 0.65
Abstract · 21 pages, 7 figures, Code and data: https://github.com/PratikGhawate/ai-personalized-health-intelligence

Artificial intelligence is transforming personalized healthcare, yet fragmented clinical, self reported, and wearable evidence remains difficult to interpret and trace. We present CareGraph, an auditable hybrid AI framework that converts heterogeneous records into prioritized trends, missing context indicators, bounded next steps, discussion questions, and provenance linked explanations. CareGraph organizes evidence without diagnosing, predicting outcomes, selecting treatment, or making autonomous clinical decisions. Its pipeline covers deterministic analysis, context detection, graph construction, constrained language model synthesis, evidence validation, safety controls, and release gating. Tests used synthetic cohorts of 400 patients each for development, validation, and holdout. On holdout data, a frozen ordinary least squares trend rule with a sufficiency gate achieved 0.827 accuracy, 0.837 macro F1 with a 95 percent confidence interval of 0.819 to 0.854, and 0.974 insufficient data F1. Missing context detection achieved 0.815 strict micro F1 versus 0.318 for the legacy detector. On an authored holdout benchmark, safety ruleset version 1.2 achieved 1.000 precision, 0.950 recall, and 0.974 F1. An audit requiring graph retrieval across 80 patients yielded 79 syntheses and 78 presentations without fallback; one output was blocked and one failed closed because of an invalid evidence key. Against monolithic GPT 5.6 on 56 matched patients, CareGraph was faster at 40.15 versus 49.62 seconds, shorter at 661 versus 1,163 words, and showed better exploratory lexical alignment with longitudinal targets; the baseline used fewer tokens and cited more raw evidence. Graph auditing verified provenance and deterministic retrieval; incremental graph effects on generation require paired evaluation. CareGraph offers a safety bounded foundation for intelligent personalized health systems.

0.42

MediSkill-Evo: Process-Constrained Self-Evolution for Evidence-Grounded Clinical Interaction

cs.AI ·2026-08-24 ·Ruoyu Wu, Shenfu Xie, Yinqian Sun, Haibo Tong, Feifei Zhao
code/data similarity 0.62
Abstract

Interactive clinical agents operate under partial observability, so reliable care depends on reaching the correct diagnosis through evidence-grounded, safe interactions. Yet existing agents struggle to convert experience into reusable process knowledge with explicit provenance and authority. To address this gap, we introduce MediSkill-Evo, which self-evolves governed process knowledge without fine-tuning the backbone. It realizes this self-evolution by updating clinical, process, symbolic, and visual knowledge in four typed banks under type-specific validation and scope rules. The Process-Constrained Preference Harness then turns validated knowledge into action by grounding candidates in evidence and prioritizing safer decisions. We evaluate on 300 MIMIC-IV-derived FullChain encounters, 180 hard-isolation conditions covering six process obligations, and 100 multimodal NEJM image-diagnosis cases. On Qwen FullChain, MediSkill-Evo improves diagnosis accuracy by 7.81% and treatment-intent coverage by 70.67% over the best-performing prior agent, while reducing critical failures by 43.04%. Under stress, it improves the stress-process composite by 7.77% and required-action completion by 12.41% over the best-performing agent for each metric, with stronger patient-fact, temporal-evidence, and triage-red-flag recovery and no controller-scored errors in unavailable-evidence, treatment, and triage safety checks. On multimodal NEJM diagnosis, MediSkill-Evo with optional MedSAM localization improves diagnosis accuracy by 2.56% and core score by 18.96% over the best-performing memory agent. Code is available at https://anonymous.4open.science/r/mediskill-evo_anonymous-68E7.

0.66

When Clinical Judgment Becomes a Predictive Shortcut: Two Questions Clinical AI Must Answer Before Deployment

cs.AI ·2026-09-22 ·Jing Yang, Long R. Jiao, Zongjiu Zhang, Xiujun Cai
similarity 0.62
Abstract · 27 pages, 1 figure, 3 tables, 1 box; includes Multimedia Appendix 1

Clinical AI can predict outcomes using information generated by existing clinical judgment. Such performance alone cannot establish usefulness before recognition or across care processes. We propose evidence requirements matched to intended use and information conditions, with additional state-reference and proxy-relative timing tests for stronger recognition claims. This framework helps hospitals assess whether the conditions supporting performance hold when assistance is most needed. These questions remain outside current evaluation practice leakage checks, overall predictive performance, and external validation do not address them; the framework makes them explicit and specifies the direct evidence required to answer them.

0.19

HIPAA-Compliant AI Deployment Patterns in Clinical Settings: Privacy-Preserving Techniques and Governance Controls

cs.CY ·2026-08-13 ·Vinod Dhiman
similarity 0.62
Abstract

Artificial intelligence (AI) is moving from research prototypes into clinical workflows, yet the deployment of AI systems that process protected health information (PHI) remains constrained by the U.S. Health Insurance Portability and Accountability Act (HIPAA) and by the absence of shared engineering guidance for satisfying it. Existing work tends to treat privacy-preserving machine learning and regulatory governance as separate concerns, leaving practitioners without a concrete mapping from architectural decisions to compliance obligations. This paper contributes a catalog of five reusable deployment patterns for clinical AI that jointly address the HIPAA Privacy and Security Rules: a de-identified analytics zone, cross-entity federated learning, confidential inference within trusted execution environments, a PHI-minimizing retrieval-augmented clinical assistant, and a synthetic data sandbox for development. Each pattern is specified in terms of context, governing forces, structure, and residual risk, and is mapped to the administrative, physical, and technical safeguards of the HIPAA Security Rule as well as to the NIST AI Risk Management Framework and ISO/IEC~42001. We further present a threat model for clinical AI and a decision procedure for selecting patterns based on data sensitivity, trust boundaries, and latency requirements. The goal is to give security engineers, compliance owners, and clinical informaticists a common vocabulary that turns abstract regulatory duties into verifiable architectural controls.

0.04

PrivMeSA: Privacy-Aware Self-Evolving Multi-Agent System for Medicine via Local-Remote LLM Collaboration

cs.AI ·2026-09-29 ·Dannong Wang, Yuran Zhang, Bian Sun, Alex Stinard, Yuzhang Shang +2 more
benchmark similarity 0.61
Abstract

Clinical large language model (LLM) agents deployed locally can consult more capable remote models, but doing so risks exposing patient information. Privacy-conscious delegation places disclosure decisions with a local agent, yet removing explicit identifiers is insufficient: quasi-identifiers can accumulate across multi-turn consultations and repeated patient visits to enable re-identification. We introduce PrivMeSA, a privacy-aware self-evolving multi-agent system that learns to control disclosure and retains remote expertise for local reuse. A local agent manages each encounter and consults remote specialists that may request additional information. Reinforcement learning balances task accuracy against direct disclosure and registry-based re-identification risk, with privacy evaluated over the complete outbound transcript of each encounter. A local lesson memory distills completed consultations into generalized clinical guidance and retrieves relevant lessons before transmission, allowing subsequent cases to reuse expertise without another remote exchange. Memory grows without additional outcome labels or parameter updates. On an emergency-department benchmark built from MIMIC-IV-ED records, PrivMeSA improves mean task accuracy over delegation by up to 15.8 percentage points. In the same setting, PrivMeSA reduces the disclosure of personal details from 98.0% to 0.2% of cases and the share of cases in which the patient can be narrowed to ten or fewer registry patients from 74% to 0%.

0.16

Right Diagnosis, Unsafe Route: Auditing Clinical AI Decision Trajectories and Corrective Oversight for Validity and Potential Harm

cs.AI ·2026-11-17 ·Guanqiao Chen, Wei Jiang, Shu Zhang, Qian Lin, Guanxu Yu +3 more
benchmarkcode/data similarity 0.61
Abstract

A clinical AI system can reach a correct final diagnosis through intermediate decisions that could have harmed the patient, and can repair an error while introducing new risks. Most evaluations score final diagnoses; even stepwise benchmarks, which release a case's evidence over time, score whether systems reach the right diagnosis or gather the right information, not whether the decisions a patient passes through are safe. We make patient safety the target of stepwise evaluation. A trajectory audit replays real admissions checkpoint by checkpoint, lets each system decide with only the evidence released so far, and rates every test, treatment and disposition for its potential harm to the patient and, separately, for clinical validity, against the documented final diagnosis and physician-written disease rubrics yet on the evidence available when the decision was made. An LLM judge scores every decision, and a physician reference standard (triple annotation and senior adjudication of a stratified sample) calibrates the rates. An oversight audit branches each trajectory at its first actionable error and measures, on the same branches, whether corrective feedback repairs the error and whether it introduces new harm. Across 300 cases from a hospital cardiology cohort, MIMIC-IV and the public ASCENT benchmark, with up to seven AI systems per source, 55.2% of hospital trajectories reaching an acceptable final diagnosis passed through a decision with moderate or severe potential harm and 24.8% through a clinically unacceptable one; the harm rates were 76.2% on MIMIC-IV and 39.6% on ASCENT. Structured corrections resolved 73.6% of first errors versus 24.8% after bare rejection, yet new potentially unsafe decisions followed 30.2% of corrections versus 19.7% of rejections. A correct final diagnosis does not certify a safe trajectory, and a successful correction does not certify a safe recovery.

0.36

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

cs.AI cs.HC ·2026-08-31 ·Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu
similarity 0.60
Abstract

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

0.13

Operation-aware Multimodal Clinical Decision Support System for ICU Discharge Risk Assessment

cs.LG ·2026-11-09 ·Guoqing Zhang, Rafik Hadfi, Takayuki Ito
benchmarkcode/data similarity 0.59
Abstract · 14 pages, 2 figures. Code available at https://github.com/KuoChing-cmd/ClinicalNoteAgent/

Unplanned 30-day intensive care unit (ICU) readmission is a critical benchmark for evaluating healthcare quality. Most predictive models assume readmission risk depends solely on a patient's individual pathophysiological state, ignoring hospital operational context and resource capacity. In practice, discharge decisions are dynamic trade-offs between patient stability and bed turnover pressures. To address this gap, we develop an Operation-aware Multimodal Clinical Decision Support System (CDSS) for ICU discharge risk assessment. The system combines multi-agent collaborative extraction with self-evolving retrieval-augmented generation (RAG) to eliminate template noise from progress notes, while constructing departmental workload indicators alongside admission flow features, continuous vital signs, and sparse medical codes (ICD/DRG). Addressing severe class imbalance (about 10.5% readmissions) and alarm fatigue, we implement data normalization, class reweighting, and decision-threshold calibration. In 20 independent runs across 20,000 ICU stays from MIMIC-III, empirical findings demonstrate that: vital signs alone have limited predictive capacity under real-world class imbalance (PR-AUC of 0.1387 +/- 0.0086); directly concatenating raw text embeddings degrades decision tree performance (XGBoost and LightGBM PR-AUC drop to 0.3893 and 0.4030); whereas an end-to-end multimodal fine-tuning architecture (Transformer E2E FineTune) utilizing layer-wise parameter freezing and differential learning rates reverses text negative transfer, achieving the highest AUROC of 0.8288 +/- 0.0110, PR-AUC of 0.4373 +/- 0.0310, and F1-Score of 0.4757 +/- 0.0196. Operational indicators supply independent risk signals, laying an engineering foundation for high-utility clinical decision support tools.

0.37